ClinicalTrials.gg
RecruitingNCT07866482Updated Oct 8, 2026

Nano-Silver Versus Bioactive Glass for Primary Teeth Exposed to Therapeutic Radiation

An interventional study of Nano Silver Fluoride and Bioactive Glass Gel in Radiation Caries, sponsored by Faculty of Dental Medicine for Girls. Recruiting at 1 site in Egypt. Open to participants aged 6 Years to 10 Years. Per ClinicalTrials.gov, last updated 2026-10-08.

Sponsored by Faculty of Dental Medicine for Girls · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Started Jul 2026; still recruiting 4 months later.
Updated Oct 8, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
6 Years to 10 Years
Sex
All
01

Study summary

This study aims to evaluate and compare the remineralizing and antimicrobial effects of nano silver fluoride and bioactive glass gel on primary teeth exposed to therapeutic radiation. The study includes both in vitro and in vivo components. The clinical component will include 30 pediatric patients aged 6-10 years undergoing therapeutic head and neck radiotherapy. Participants will be randomly allocated into two groups to receive either nano silver fluoride or bioactive glass gel. The effects of the interventions will be evaluated using salivary pH and bacterial count measurements. The laboratory component will evaluate changes in irradiated primary tooth enamel, including surface morphology, mineral content, and microhardness.

Read the detailed description

The study consists of in vitro and in vivo components designed to evaluate the effects of therapeutic radiation on primary teeth and to compare the effects of nano silver fluoride and bioactive glass gel.

For the in vitro component, 12 sound extracted primary molars will be sectioned mesiodistally to obtain 24 enamel specimens. The specimens will be exposed to therapeutic radiation and randomly assigned to two groups. One group will receive nano silver fluoride solution, while the other will receive bioactive glass gel. Enamel specimens will be evaluated at baseline, after radiation exposure, and after application of the assigned material. Assessments will include scanning electron microscopy for surface morphology, energy-dispersive X-ray spectroscopy for mineral analysis, and Vickers microhardness testing.

For the in vivo component, 30 pediatric patients undergoing therapeutic head and neck radiotherapy will be randomly allocated into two groups of 15 participants. The first group will receive a single application of nano silver fluoride solution for one minute. The second group will use bioactive glass gel once daily for one minute for seven days. Clinical assessment will include measurement of salivary pH and bacterial counts before and after application of the assigned intervention.

02

Conditions studied

  • Radiation Caries

Keywords

  • Radiation Caries
  • Primary Teeth
  • Head and Neck Radiotherapy
  • Nano Silver Fluoride
  • Bioactive Glass
  • Enamel Remineralization
  • Pediatric Dentistry
03

In context

Lead sponsor

Faculty of Dental Medicine for Girls is the lead sponsor of 54 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
6 Years to 10 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Pediatric patients undergoing therapeutic head and neck radiotherapy.
  • Age 6 to 10 years.
  • Presence of at least one sound primary tooth.
  • The oral cavity lies within the radiotherapy field during treatment.
  • Written obtained from a parent or legal guardian.

Exclusion criteria

Exclusion Criteria:

  • Systemic diseases affecting tooth mineralization.
  • Use of medications known to influence salivary flow or enamel integrity, other than radiotherapy.
  • Edentulous upper and lower jaws.
  • Extensive dental caries or severe enamel defects.
  • Habitual mouth breathing.
  • Uncooperative patients or lack of parental consent.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    Nano Silver Fluoride

    Participants will receive a single application of nano silver fluoride solution for 1 minute.

    Other: Nano Silver Fluoride

  • Experimental
    Bioactive Glass Gel

    Participants will receive bioactive glass gel once daily for 1 minute for 7 days

    Other: Bioactive Glass Gel

Interventions

  • OtherNano Silver Fluoride

    Nano silver fluoride solution will be topically applied once for 1 minute

    Also known as: nano silver flouride

  • OtherBioactive Glass Gel

    Bioactive glass gel will be topically applied once daily for 1 minute for 7 consecutive days

06

What researchers measure

Primary outcomes

  1. Change in Salivary Bacterial Count

    Salivary bacterial count will be measured to evaluate the antimicrobial effect of nano silver fluoride compared with bioactive glass gel.

    Time frame: Baseline and 1 week after intervention

  2. Change in Salivary pH

    Salivary pH will be measured before and after the intervention to evaluate changes following treatment with nano silver fluoride or bioactive glass gel

    Time frame: Baseline and 1 week after intervention

07

Study locations

1 of 1 sites recruiting
08

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 8, 2026
Show all 1 update
  1. Oct 8, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07866482
Lead sponsor
Faculty of Dental Medicine for Girls
Responsible party
somia mohamed refat mostafa selim (Assistant Lecturer, Faculty of Dental Medicine for Girls) — Principal investigator
First posted
Oct 8, 2026
Start date
Jul 11, 2026
Primary completion
Dec 31, 2026 (estimated)
Completion
Feb 15, 2027 (estimated)
Last update
Oct 8, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion